SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-000428
Accepted
2021-02-04 00:15:40
Documents
1
Effectiveness Date
2021-02-03
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 601
  Complete submission text file 9999999995-21-000428.txt   1842
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-68314 | Film No.: 21588695
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences